Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01330628 · ClinicalTrials.gov registry record · Phase 2
Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis
A Phase 2 study, sponsored by Spectranetics Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 252
- Enrollment target
NCT01330628 is a Phase 2 study that has completed, run by Spectranetics Corporation. The registered enrollment target is 252 participants.
The verdict
NCT01330628, a Phase 2 study, has completed, sponsored by Spectranetics Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 252 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and efficacy of laser atherectomy with balloon angioplasty compared to balloon angioplasty alone in the treatment of above the knee peripheral artery in-stent restenosis.
Interventions
- DEVICE Turbo Elite Laser and Turbo Tandem Laser Guide Catheters
- PROCEDURE Balloon angioplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01330628
The ClinicalTrials.gov registry entry for NCT01330628 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spectranetics Corporation, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Turbo Elite Laser and Turbo Tandem Laser Guide Catheters is the first listed.
NCT01330628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01330628 about?
NCT01330628 is a clinical study titled "Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis". The purpose of the study is to evaluate the safety and efficacy of laser atherectomy with balloon angioplasty compared to balloon angioplasty alone in the treatment of above the knee peripheral artery in-stent restenosis.
What is the current status of trial NCT01330628?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 252 participants. The study started on 2011-06. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01330628?
The interventions under investigation include: Turbo Elite Laser and Turbo Tandem Laser Guide Catheters (DEVICE), Balloon angioplasty (PROCEDURE).
Who is sponsoring clinical trial NCT01330628?
This trial is sponsored by Spectranetics Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.